162 related articles for article (PubMed ID: 1481205)
21. A novel DRB1 allele (DRB1*1415) formed by interallelic crossing over between the DRB1*1404 and the DRB1*0802 or 0804 alleles.
Fogdell A; Olerup O
Tissue Antigens; 1994 May; 43(5):327-9. PubMed ID: 7940503
[No Abstract] [Full Text] [Related]
22. A new HLA-DRB1 allele formed by an intraexonic interallelic crossover.
Horne C; Goodfellow PJ; McDonald HL; Junker AK; Keown PA; Hoar DI
Tissue Antigens; 1993 Sep; 42(3):141-3. PubMed ID: 7904383
[No Abstract] [Full Text] [Related]
23. A new HLA-DRB1*11 allele (DRB1*1109) differing at codons 32, 34 and 37.
Williams F; Hughes DJ; Middleton D
Tissue Antigens; 1994 Jul; 44(1):63-4. PubMed ID: 7974472
[No Abstract] [Full Text] [Related]
24. A new HLA-DR4 allele with a DR11 alpha-helix sequence.
Tiercy JM; Gebuhrer L; Betuel H; Mach B; Jeannet M
Tissue Antigens; 1993 Feb; 41(2):97-101. PubMed ID: 8475495
[No Abstract] [Full Text] [Related]
25. The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule.
Weyand CM; Hicok KC; Hunder GG; Goronzy JJ
J Clin Invest; 1992 Dec; 90(6):2355-61. PubMed ID: 1469092
[TBL] [Abstract][Full Text] [Related]
26. Rheumatoid arthritis in Israeli Jews: shared sequences in the third hypervariable region of DRB1 alleles are associated with susceptibility.
Gao X; Gazit E; Livneh A; Stastny P
J Rheumatol; 1991 Jun; 18(6):801-3. PubMed ID: 1895259
[TBL] [Abstract][Full Text] [Related]
27. Sequence of HLA-DRB1*0431 allele.
Bettens F; Kervaire B; Tiercy JM
Tissue Antigens; 1999 Apr; 53(4 Pt 1):378-80. PubMed ID: 10323343
[TBL] [Abstract][Full Text] [Related]
28. A possible association between basic amino acids of position 13 of DRB1 chains and autoimmune hepatitis.
Ota M; Seki T; Kiyosawa K; Furuta S; Hino K; Kondo T; Fukushima H; Tsuji K; Inoko H
Immunogenetics; 1992; 36(1):49-55. PubMed ID: 1350267
[TBL] [Abstract][Full Text] [Related]
29. A novel HLA DR52-associated DRB1 allele (DRB1*1311).
Dufossé F; Cracco P; Becuwe D; Lemaitre V; Huart JJ
Tissue Antigens; 1994 Apr; 43(4):271-3. PubMed ID: 8085265
[No Abstract] [Full Text] [Related]
30. Is HLA-DR4 or the HLA-DRB1*0402 allele associated with decreased risk for CML?
Pawelec G; Wagner W
Leukemia; 2001 Jan; 15(1):192-3. PubMed ID: 11243394
[No Abstract] [Full Text] [Related]
31. A novel HLA-DRB1-DR2 allele associated with HLA mistyping.
Rosenlicht JW; Hartung K; Deicher H; Frey J
Immunogenetics; 1993; 37(6):479. PubMed ID: 8436426
[No Abstract] [Full Text] [Related]
32. Re-evaluation of DRB1*0702: evidence for only one allele, DRB1*0701, encoding the beta chain of the HLA-DR7 antigen.
Guethlein LA; Bias WB; Schmeckpeper BJ
Tissue Antigens; 1994 Feb; 43(2):124-8. PubMed ID: 8016840
[No Abstract] [Full Text] [Related]
33. A silent mutation in HLA-DRB1*0301 can affect oligotyping.
Eberle M; Baxter-Lowe LA
Tissue Antigens; 1992 Sep; 40(3):150-2. PubMed ID: 1440569
[No Abstract] [Full Text] [Related]
34. Distribution of HLA class II alleles among Scandinavian patients with systemic lupus erythematosus (SLE): an increased risk of SLE among non[DRB1*03,DQA1*0501,DQB1*0201] class II homozygotes?
Skarsvåg S; Hansen KE; Holst A; Moen T
Tissue Antigens; 1992 Sep; 40(3):128-33. PubMed ID: 1440567
[TBL] [Abstract][Full Text] [Related]
35. Predominance of HLA-DRB1*0405 in Korean patients with rheumatoid arthritis.
Kim HY; Kim TG; Park SH; Lee SH; Cho CS; Han H
Ann Rheum Dis; 1995 Dec; 54(12):988-90. PubMed ID: 8546532
[TBL] [Abstract][Full Text] [Related]
36. Dissection of the HLA-DR4 peptide repertoire in endocrine epithelial cells: strong influence of invariant chain and HLA-DM expression on the nature of ligands.
Muntasell A; Carrascal M; Alvarez I; Serradell L; van Veelen P; Verreck FA; Koning F; Abian J; Jaraquemada D
J Immunol; 2004 Jul; 173(2):1085-93. PubMed ID: 15240697
[TBL] [Abstract][Full Text] [Related]
37. A simple nonradioactive method of DNA typing for subsets of HLA-DR4: prevalence data on HLA-DR4 subsets in three diabetic population groups.
Ju LY; Gu XF; Bardie R; Krishnamoorthy R; Charron D
Hum Immunol; 1991 Aug; 31(4):251-8. PubMed ID: 1680838
[TBL] [Abstract][Full Text] [Related]
38. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.
Ito K; Bian HJ; Molina M; Han J; Magram J; Saar E; Belunis C; Bolin DR; Arceo R; Campbell R; Falcioni F; Vidović D; Hammer J; Nagy ZA
J Exp Med; 1996 Jun; 183(6):2635-44. PubMed ID: 8676084
[TBL] [Abstract][Full Text] [Related]
39. HLA-DRB1 genotyping in patients with rheumatoid arthritis in Taiwan.
Yen JH; Chen JR; Tsai WJ; Tsai JJ; Liu HW
J Rheumatol; 1995 Aug; 22(8):1450-4. PubMed ID: 7473464
[TBL] [Abstract][Full Text] [Related]
40. Oligonucleotide typing analysis for the linkage disequilibrium between the polymorphic DRB1 and DRB5 loci in DR2 haplotypes.
Tiercy JM; Jeannet M; Mach B
Tissue Antigens; 1991 Apr; 37(4):161-4. PubMed ID: 1926124
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
